FNWD:NASDAQFinward Bancorp Analysis
Data as of 2026-04-04 - not real-time
$35.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Finward Bancorp (FNWD) is trading at $35.04, notably above its DCF‑derived fair value of $25.90, suggesting a premium of roughly 35% relative to intrinsic estimates. The stock’s trailing P/E of 18.6 exceeds the regional bank industry average of 16.6, while the P/B ratio of 0.87 indicates a price below book value, offering a partial cushion. Dividend yield stands at 1.37% with a modest payout ratio of 25.5%, and the company generated $9.9 M of operating cash flow, comfortably covering the annual dividend outlay. Low leverage (debt‑to‑equity near zero) and a beta of 0.25 point to limited market‑related volatility, though 30‑day price volatility is elevated at 28% and trading volume is on a downtrend, flagging liquidity concerns.
Technical indicators show the stock below its 20‑day ($36.94) and 50‑day ($36.97) simple moving averages, a bearish MACD histogram, and an RSI of 38, hinting at limited upside momentum in the near term. Support sits at $34.59 and resistance at $38.93, with the market sentiment index at “Extreme Greed” (78.8), suggesting a potential short‑term pullback before any sustained rally. Investors may consider a cautious stance: hold or add on dips for dividend income while monitoring price action around key support levels.
Technical indicators show the stock below its 20‑day ($36.94) and 50‑day ($36.97) simple moving averages, a bearish MACD histogram, and an RSI of 38, hinting at limited upside momentum in the near term. Support sits at $34.59 and resistance at $38.93, with the market sentiment index at “Extreme Greed” (78.8), suggesting a potential short‑term pullback before any sustained rally. Investors may consider a cautious stance: hold or add on dips for dividend income while monitoring price action around key support levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 20‑day and 50‑day SMA
- Bearish MACD and decreasing volume
- Proximity to support level at $34.59
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Improving earnings outlook (forward EPS $3.06)
- Low payout ratio and strong cash flow
- Low beta indicating defensive profile
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- DCF fair value suggests upside correction risk
- Stable dividend and solid book value
- Sector headwinds for regional banks
Key Metrics & Analysis
Financial Health
Revenue Growth-1.90%
Profit Margin12.21%
P/E Ratio18.6
ROE4.96%
ROA0.40%
P/B Ratio0.9
Op. Cash Flow$9.9M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI38.7
Support$34.59
Resistance$38.93
MA 20$36.94
MA 50$36.97
MA 200$33.57
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$25.90
Target Price$39.00
Upside/Downside11.30%
GradeFair
TypeBlend
Dividend Yield1.37%
Risk Assessment
Beta0.25
Volatility28.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.